Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Prostatic Neoplasms
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
Filters
3
NCT01784913
2024-12-16
UV1/hTERT2012P
Ultimovacs ASA
Phase 1/2
Completed
22 enrolled
NCT01322490
2019-09-04
Prospect
Bavarian Nordic
Phase 3
Completed
1,297 enrolled
16 charts